Showing 461 - 480 results of 128,670 for search '(( i d decrease ) OR ( 5 ((((step decrease) OR (nn decrease))) OR (a decrease)) ))', query time: 1.70s Refine Results
  1. 461

    Vectorized siRNA TMPRSS2-ERG IV-SQ impaired tumour growth and restored differentiation <i>in vivo</i>. by Giorgia Urbinati (554921)

    Published 2015
    “…Using the Kruskal & Wallis followed by Tukey and/or Dunnet test, a statistical decrease (*** = <i>p</i><0.001) of tumour growth was observed when mice were treated with siRNA TMPRSS2-ERG IV-SQ NPs. …”
  2. 462
  3. 463
  4. 464
  5. 465
  6. 466

    Decreased synaptic density in the CA1 hippocampal area. by Cong Cao (281298)

    Published 2013
    “…<p>PSD-95 (green, A and D) and SYN (red, B and E) antibodies were used to stain synapses (merged, C and F) in stratum radiatum (SR) of the hippocampal area CA1. …”
  7. 467
  8. 468
  9. 469
  10. 470
  11. 471
  12. 472
  13. 473

    Knockdown of VGLUT1 results in a concomitant decrease in synaptic expression of synapsin and synaptophysin. by Corbett T. Berry (296520)

    Published 2013
    “…(<b>E</b>) Synaptophysin was not decreased in KD neurons co-expressing VGLUT1 (<i>V1</i>, VGLUT1 expressing neurons; p = 0.940; n = 244 and 96 puncta from 13 and 9 axons for SCR and V1, respectively, from a representative experiment. …”
  14. 474

    Activin A decreases MPTP and LPS-induced inflammation. by Sandy Stayte (728461)

    Published 2017
    “…<p>Stereological quantification of the left SNpc demonstrated activin A significantly decreased the number of GFAP-immunoreactive cells (A) and Iba1-immunoreactive cells (B) in the SNpc following MPTP. …”
  15. 475
  16. 476

    Grey matter concentration decreases for (A) tinnitus duration. by Sven Vanneste (202029)

    Published 2015
    “…<p>Grey matter decrease projected onto a T1-weighted image. Maximum intensity projection with a threshold of <i>p</i> < .001 (uncorrected) at both voxel and cluster level. …”
  17. 477

    Nimodipine does not decrease markers of neuritic dystrophy in 5XFAD transgenic mice. by Katherine R. Sadleir (12035242)

    Published 2022
    “…Similarly, BACE1, LAMP1 and LC3B-II/ LC3B-I were also increased in nimodipine-treated 5XFAD compared to nimodipine treated non-transgenic mice, indicating that nimodipine did not decrease the accumulation of these dystrophic neurite marker proteins. …”
  18. 478
  19. 479
  20. 480